|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 215.00 TWD | -0.23% |
|
-0.23% | -13.31% |
| 11-06 | ASROCK Incorporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
| 29/09/25 | ASRock Sells Minority Stake in Unit for NT$351 Million | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 10.57 | 13.85 | 4.83 | 4.92 | 6.15 | |||||
Return on Total Capital | 16.71 | 23.5 | 8.02 | 7.7 | 10.52 | |||||
Return On Equity % | 21.92 | 30.56 | 13.88 | 11 | 16.43 | |||||
Return on Common Equity | 20.81 | 31.39 | 12.95 | 11.27 | 14.79 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 21.51 | 28.15 | 21.61 | 20.16 | 18.99 | |||||
SG&A Margin | 5.35 | 6.27 | 7.35 | 7.07 | 6.32 | |||||
EBITDA Margin % | 10.61 | 15.73 | 7.42 | 6.74 | 7.02 | |||||
EBITA Margin % | 10.4 | 15.51 | 6.97 | 6.11 | 6.57 | |||||
EBIT Margin % | 10.37 | 15.47 | 6.92 | 6.04 | 6.52 | |||||
Income From Continuing Operations Margin % | 8.42 | 12.45 | 7.17 | 5.15 | 6.16 | |||||
Net Income Margin % | 7.61 | 12.05 | 6.23 | 4.84 | 5.02 | |||||
Net Avail. For Common Margin % | 7.61 | 12.05 | 6.23 | 4.84 | 5.02 | |||||
Normalized Net Income Margin | 5.66 | 9.28 | 4.28 | 3.72 | 3.58 | |||||
Levered Free Cash Flow Margin | 6.03 | 2.16 | 4.99 | 12.93 | -2.64 | |||||
Unlevered Free Cash Flow Margin | 6.04 | 2.16 | 5.03 | 12.95 | -2.63 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.63 | 1.43 | 1.12 | 1.3 | 1.51 | |||||
Fixed Assets Turnover | 57.12 | 60.7 | 39.55 | 37.04 | 24.64 | |||||
Receivables Turnover (Average Receivables) | 10.96 | 11.15 | 9.7 | 10.6 | 11.59 | |||||
Inventory Turnover (Average Inventory) | 2.6 | 1.83 | 1.51 | 2.11 | 2.54 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.57 | 2.2 | 2.41 | 2.52 | 1.92 | |||||
Quick Ratio | 1.17 | 0.77 | 0.95 | 1.28 | 0.8 | |||||
Operating Cash Flow to Current Liabilities | 0.31 | 0.15 | 0.2 | 0.49 | 0.1 | |||||
Days Sales Outstanding (Average Receivables) | 33.41 | 32.74 | 37.62 | 34.43 | 31.58 | |||||
Days Outstanding Inventory (Average Inventory) | 140.86 | 199.87 | 241.1 | 173.16 | 144.11 | |||||
Average Days Payable Outstanding | 64.69 | 72.51 | 116.24 | 83.89 | 69.36 | |||||
Cash Conversion Cycle (Average Days) | 109.58 | 160.09 | 162.47 | 123.71 | 106.33 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 1.08 | 1.04 | 7.83 | 1.6 | 4.61 | |||||
Total Debt / Total Capital | 1.07 | 1.02 | 7.26 | 1.57 | 4.41 | |||||
LT Debt/Equity | 0.56 | 0.55 | 0.45 | 0.92 | 0.52 | |||||
Long-Term Debt / Total Capital | 0.55 | 0.54 | 0.42 | 0.91 | 0.5 | |||||
Total Liabilities / Total Assets | 37.62 | 44.7 | 39.77 | 38.21 | 47.24 | |||||
EBIT / Interest Expense | 2.07K | 3.81K | 101.27 | 213.67 | 351.19 | |||||
EBITDA / Interest Expense | 2.16K | 3.93K | 112.76 | 249.28 | 392.05 | |||||
(EBITDA - Capex) / Interest Expense | 2.12K | 3.87K | 105.26 | 246.23 | 140.61 | |||||
Total Debt / EBITDA | 0.04 | 0.03 | 0.53 | 0.11 | 0.26 | |||||
Net Debt / EBITDA | -1.73 | -1.08 | -2.44 | -3.56 | -2.29 | |||||
Total Debt / (EBITDA - Capex) | 0.04 | 0.03 | 0.57 | 0.11 | 0.71 | |||||
Net Debt / (EBITDA - Capex) | -1.76 | -1.1 | -2.61 | -3.6 | -6.39 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 33.52 | 10.33 | -13.37 | 10.93 | 35.08 | |||||
Gross Profit, 1 Yr. Growth % | 57.91 | 44.44 | -33.49 | 3.48 | 27.22 | |||||
EBITDA, 1 Yr. Growth % | 135.76 | 63.49 | -59.13 | 0.84 | 40.55 | |||||
EBITA, 1 Yr. Growth % | 141.31 | 64.55 | -61.09 | -2.79 | 45.44 | |||||
EBIT, 1 Yr. Growth % | 142.31 | 64.59 | -61.25 | -3.2 | 45.78 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 132.07 | 63.06 | -50.13 | -20.32 | 61.7 | |||||
Net Income, 1 Yr. Growth % | 128.14 | 74.68 | -55.22 | -13.81 | 40.23 | |||||
Normalized Net Income, 1 Yr. Growth % | 131.6 | 80.76 | -59.99 | -3.82 | 30.25 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 128.05 | 74.06 | -55.71 | -13.06 | 39.49 | |||||
Accounts Receivable, 1 Yr. Growth % | 1.75 | 14.96 | -13.87 | 19.42 | 27.01 | |||||
Inventory, 1 Yr. Growth % | 16.8 | 66.7 | -17.58 | -20.4 | 56.67 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 3.26 | 4.38 | 60.34 | -7.68 | 223.05 | |||||
Total Assets, 1 Yr. Growth % | 14.12 | 35.66 | -7.09 | -2.66 | 36.6 | |||||
Tangible Book Value, 1 Yr. Growth % | 11.3 | 19.88 | -0.97 | -1.06 | 14.47 | |||||
Common Equity, 1 Yr. Growth % | 11.36 | 19.85 | -0.95 | -0.85 | 14.49 | |||||
Cash From Operations, 1 Yr. Growth % | 0.42 | -24.24 | 11.38 | 131.09 | -65.01 | |||||
Capital Expenditures, 1 Yr. Growth % | 26.13 | 32.99 | 89.19 | -81.32 | 7.2K | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 0.14 | -60.48 | 99.99 | 187.6 | -127.57 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 0.05 | -60.46 | 101.46 | 185.55 | -127.41 | |||||
Dividend Per Share, 1 Yr. Growth % | 100 | 62.5 | -38.46 | -13.75 | -23.19 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 32.56 | 21.37 | -2.23 | -1.97 | 22.41 | |||||
Gross Profit, 2 Yr. CAGR % | 30.33 | 51.03 | -1.99 | -17.04 | 14.74 | |||||
EBITDA, 2 Yr. CAGR % | 64.39 | 96.32 | -18.26 | -35.8 | 19.05 | |||||
EBITA, 2 Yr. CAGR % | 66.32 | 99.26 | -19.98 | -38.5 | 18.9 | |||||
EBIT, 2 Yr. CAGR % | 67.02 | 99.7 | -20.14 | -38.75 | 18.79 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 59.53 | 94.53 | -9.82 | -36.96 | 13.51 | |||||
Net Income, 2 Yr. CAGR % | 51.62 | 99.63 | -11.56 | -37.87 | 9.94 | |||||
Normalized Net Income, 2 Yr. CAGR % | 52.85 | 104.61 | -14.96 | -37.97 | 11.93 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 51.79 | 99.24 | -12.2 | -37.95 | 10.12 | |||||
Accounts Receivable, 2 Yr. CAGR % | 0.02 | 8.15 | -0.49 | 1.42 | 23.16 | |||||
Inventory, 2 Yr. CAGR % | 8.41 | 39.54 | 17.21 | -19 | 11.67 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 10.14 | 3.82 | 29.37 | 21.66 | 72.7 | |||||
Total Assets, 2 Yr. CAGR % | 11.85 | 24.43 | 12.27 | -4.9 | 15.31 | |||||
Tangible Book Value, 2 Yr. CAGR % | 6.22 | 15.51 | 8.96 | -1.02 | 6.42 | |||||
Common Equity, 2 Yr. CAGR % | 6.23 | 15.53 | 8.95 | -0.9 | 6.55 | |||||
Cash From Operations, 2 Yr. CAGR % | 0.47 | -12.78 | -8.14 | 60.43 | -10.08 | |||||
Capital Expenditures, 2 Yr. CAGR % | -3.69 | 29.51 | 58.62 | -40.55 | 269.36 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -15.91 | -37.09 | -11.1 | 139.83 | -10.95 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -15.86 | -37.1 | -10.75 | 139.85 | -11.52 | |||||
Dividend Per Share, 2 Yr. CAGR % | 41.42 | 80.28 | 0 | -27.15 | -18.61 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 24.81 | 24.69 | 8.47 | 1.97 | 9.09 | |||||
Gross Profit, 3 Yr. CAGR % | 25.29 | 34.87 | 14.9 | -0.2 | -4.33 | |||||
EBITDA, 3 Yr. CAGR % | 52.46 | 64.09 | 16.35 | -12.33 | -16.64 | |||||
EBITA, 3 Yr. CAGR % | 53.49 | 65.73 | 15.6 | -14.62 | -18.06 | |||||
EBIT, 3 Yr. CAGR % | 54.4 | 66.21 | 15.62 | -14.85 | -18.22 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 50.51 | 60.7 | 23.58 | -13.47 | -13.71 | |||||
Net Income, 3 Yr. CAGR % | 42.71 | 58.95 | 21.3 | -12.31 | -18.5 | |||||
Normalized Net Income, 3 Yr. CAGR % | 39 | 61.64 | 18.76 | -11.4 | -20.56 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 41.03 | 58.88 | 20.69 | -12.49 | -18.71 | |||||
Accounts Receivable, 3 Yr. CAGR % | 5.56 | 4.77 | 0.25 | 5.75 | 9.32 | |||||
Inventory, 3 Yr. CAGR % | 21.32 | 25.13 | 17.08 | 3.03 | 0.92 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 8.27 | 8.18 | 20 | 15.61 | 68.47 | |||||
Total Assets, 3 Yr. CAGR % | 9.32 | 19.29 | 12.88 | 7.06 | 7.3 | |||||
Tangible Book Value, 3 Yr. CAGR % | 6.46 | 10.59 | 9.73 | 5.51 | 3.9 | |||||
Common Equity, 3 Yr. CAGR % | 6.45 | 10.59 | 9.75 | 5.58 | 3.99 | |||||
Cash From Operations, 3 Yr. CAGR % | 49.51 | -8.55 | -5.37 | 24.93 | -3.43 | |||||
Capital Expenditures, 3 Yr. CAGR % | -15.67 | 7.25 | 46.95 | -22.25 | 195.53 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 60.68 | -34.62 | -7.5 | 31.48 | 16.62 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 60.65 | -34.58 | -7.28 | 31.52 | 16.4 | |||||
Dividend Per Share, 3 Yr. CAGR % | 25.99 | 48.12 | 26 | -4.81 | -25.85 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 19.94 | 22.65 | 13.2 | 13.25 | 13.84 | |||||
Gross Profit, 5 Yr. CAGR % | 22.09 | 32.48 | 13.57 | 11.05 | 14.84 | |||||
EBITDA, 5 Yr. CAGR % | 38.78 | 69.19 | 18.81 | 12.73 | 17.42 | |||||
EBITA, 5 Yr. CAGR % | 39.26 | 71.51 | 18.28 | 11.48 | 16.91 | |||||
EBIT, 5 Yr. CAGR % | 39.35 | 72.66 | 18.61 | 11.49 | 16.88 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 48.9 | 81.94 | 22.62 | 10.52 | 19.45 | |||||
Net Income, 5 Yr. CAGR % | 41.45 | 71.68 | 17.85 | 9.16 | 16.62 | |||||
Normalized Net Income, 5 Yr. CAGR % | 33.16 | 63.9 | 14.2 | 10.2 | 15.98 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 40.08 | 69.89 | 16.68 | 9.08 | 16.35 | |||||
Accounts Receivable, 5 Yr. CAGR % | 10.69 | 8.66 | 3.1 | 3.42 | 8.85 | |||||
Inventory, 5 Yr. CAGR % | 13.26 | 29.66 | 19.66 | 5.15 | 14.88 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 6.11 | 7.76 | 16.26 | 13.39 | 38.81 | |||||
Total Assets, 5 Yr. CAGR % | 7.58 | 14.48 | 10.49 | 8.95 | 13.85 | |||||
Tangible Book Value, 5 Yr. CAGR % | 3.38 | 7.92 | 7.45 | 5.79 | 8.4 | |||||
Common Equity, 5 Yr. CAGR % | 3.36 | 7.89 | 7.44 | 5.84 | 8.46 | |||||
Cash From Operations, 5 Yr. CAGR % | 0.7 | 13.62 | 23.04 | 14.5 | -7.28 | |||||
Capital Expenditures, 5 Yr. CAGR % | 6.07 | 28.6 | 8.58 | -15.3 | 112.46 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -4.35 | -5.87 | 26.8 | 9.96 | -8.9 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -4.37 | -5.85 | 26.99 | 10 | -9 | |||||
Dividend Per Share, 5 Yr. CAGR % | 26.19 | 45.41 | 14.87 | 11.52 | 5.79 |
- Stock Market
- Equities
- 3515 Stock
- Financials ASROCK Incorporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















